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ABSTRACT
Objectives: Intrahepatic cholestasis of pregnancy (ICP) is a liver specific disorder affecting 0.08%–27.6% pregnant women. 
It is characterized by reduced expression of the primary bile acid farnesoid receptor (FXR). In recent studies, it has been 
showed that FXR has an impact on normal glucose homeostasis. Based on that it was suggested that the level of bile acids 
correlates with glucose level. The aim of the study was to evaluate the association between ICP and gestational diabetes 
mellitus (GDM).
Material and methods: 102 singleton patients complicated by ICP were included to the study and divided into two 
groups: non-GDM group (74 patients) and GDM group (28 patients). ICP was diagnosed based on the serum bile acids 
level > 10 μmol/L and GDM with the 75 g oral glucose tolerance test and FIGO guidelines. Demographic and clinical outcome 
data (including maternal age, BMI and infant weight) and ICP and GDM biochemical markers were collected.
Results: The incidence of GDM in ICP patients was 27.45%. 73% of women included to the study developed mild choles-
tasis. Lower levels of serum bile acids were correlated with GDM group. When compared mean total bilirubin level was 
significantly higher in non-GDM group. Transaminases (ALT, AST) and neonate condition including mean birth weight 
revealed no significant difference between the groups. On the other hand, prevalence of large for gestational age was 
significantly higher in non-GDM group (p < 0.00001).
Conclusions: The incidence of ICP is higher in women with GDM.
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INTRODUCTION
Intrahepatic cholestasis of pregnancy (ICP), also known 
as obstetric cholestasis, is a liver specific disorder associated 
with elevated serum bile acids, liver function tests, pruritus 
and increased rates of adverse fetal outcomes. The incidence 
of ICP depends on demographic variation affecting 0.08–
27.6% pregnant women. The highest rate is seen in South 
America in Chile (11.8–27.6%) [1]. In Poland, estimated rate of 
ICP is 1.5% but is based on few studies on small population.
Gestational diabetes mellitus (GDM) is a disorder diagnosed 
based on hyperglycemia that is recognized for the first time 
during pregnancy. The rate of pregnant women developing the 
condition varies between 1–14% and is higher in Asian than in 
Caucasian ethnicity [2, 3]. There are few risk factors of the de-
velopment of GDM, for example obesity, age above 35 years 
old and family history of T2DM [2]. It has been showed that 
GDM has an impact on the outcome in both mother and fetus. 
It predisposes the neonate to macrosomia, hypoglycemia, 
hyperbilirubinemia, polycythemia, respiratory disorders, 
shoulder dystocia and in the future to obesity and ultimately 
diabetes. The prevalence of the disorder is increasing and it 
correlates with progressive rising of obesity and T2DM cases 
in population [4].
The direct cause of correlation between ICP and GDM 
is unknown. There is increasing amount of studies that 
show the role for the primary bile acid receptor Farnesoid 
X receptor (FXR) in glucose and lipid levels apart from its 
known impact on bile acids metabolism [5]. It is suggested 
that during gestation if the homeostasis of one mentioned 
substances is dysregulated it might correlate with higher 
risk of abnormal levels of another. One of the prospective 
study of 31 patients with ICP reported a significantly higher 
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blood glucose level while oral glucose tolerance testing 
(OGTT) [6].
Based on that it was suggested that the level of bile acids 
correlates with cholesterol and glucose level. Consequently, 
there is increasing amount of studies that ICP is associated with 
a higher risk of developing GDM. We decided to investigate 
further the correlation between these both conditions.
Objectives
The aim of this study was to investigate the association 
between ICP and GDM in a group of pregnant women diag-
nosed with ICP who undergone routing screening for GDM. 
MATERIALS AND METHODS
A total group of 5676 singleton patients who gave birth 
at the Department of Obstetrics and Gynecology between 
January 2015 and December 2017 were included in the 
retrospective study. Intrahepatic cholestasis of pregnancy 
was diagnosed according to PTGiP (Polish Gynecological 
and Obstetrics Society) recommendations and it was based 
on the serum bile acids level above > 10 μmol/L, elevated 
liver function tests and pruritus. After 24 weeks, universal 
screening for GDM was performed using the World Health 
Organization (WHO) 75 g oral glucose tolerance test (OGTT) 
and diagnostic criteria were based on the FIGO (The Interna-
tional Federation of Gynecology and Obstetrics) guidelines 
including: fasting blood glucose level above 92 mg/dL; 75 g 
OGTT 1-hour blood glucose level of ≥ 180 mg/dL; 75 g OGTT 
2-hour blood glucose level above 153 mg/dL [7]. 
Based on the upon diagnostic criteria 102 out of 5676 pa-
tients registered in the clinic during the period were diag-
nosed with ICP. They were divided into 2 groups: non-GDM 
group of 74 patients diagnosed with ICP and OGTT results 
within the reference range and GDM group of 28 patients 
diagnosed with ICP and GDM. 
Both groups were compared in terms of maternal age, 
pre-gestational BMI, pregnancy weight gain, delivery week, 
the method of delivery, the percentage of preterm birth 
and biochemical results. The groups were also compared 
in terms of neonatal status assessed using the Apgar score 
1 minute and 5 minutes after birth and other neonatal out-
comes such as birth weight.
One-factor analysis was performed with the global sig-
nificance level of 0.05. Variables were compared by means 
of Student’s t-test, Mann-Whitney’s U-test, and chi-squared 
test. 
RESULTS
5676 patients delivered in our hospital between 2015–
2017. Out of these, 485 (8.54%) developed gestational diabe-
tes mellitus. 102 (1.80%) patients were included to our study 
with diagnosis of intrahepatic cholestasis of pregnancy. 
The main maternal results of the study group are pre-
sented in the Table 1. The mean age of the patients was 
31.89 ± 4.84 (range 23–44) with 54% nulliparous and 46% 
multiparous. The mean gestational age at delivery was 
255.53 ± 15.53 (range 236–286). 73 patients (71.6%) de-
livered between 34–36 week and 6 (5.9%) before 34 week 
of gestation. Most of patients (73.6%) gave birth by cesar-
ean section. 
Figure 1 represents the prevalence of ICP in the popula-
tion and in pregnancies complicated by GDM. The results 
showed that the incidence of ICP was 3 times higher in 
patients with GDM diagnosis (p < 0.0001). Figure 2 describes 
the prevalence of GDM in the population and in pregnancies 
Table 1. The main maternal results of the study group
Variable Study group
Vaginal delivery 26.4%
Cesarean section 73.6%
Pre-pregnancy BMI ≥ 25 kg/m² [%] 33%
Gestational weight gain [kg] 11.84 ± 5.33
FGL 84.35 ± 21.94
0 h OGTT 83.15 ± 21.97
1 h OGTT 133.78 ± 50.32
2 h OGTT 117.44 ± 44.23
1.80%
5.77%
7%
6%
5%
4%
3%
2%
1%
0%
Complicated by GDMAll pregnancies
Figure 1. Prevalence of ICP in pregnancy
Figure 2. Prevalence of GDM in pregnancy
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460
Ginekologia Polska 2019, vol. 90, no. 8
www. journals.viamedica.pl/ginekologia_polska
complicated by ICP. The analysis revealed the prevalence of 
GDM tripled in a group of patients who developed ICP in 
comparison to all pregnancies (p < 0.0001). 
Patients were divided into two groups based on the 
prevalence of GDM. In non-GDM group (74 patients) were 
diagnosed with ICP and had glucose level results between 
the reference range and in GDM group (28 patients) were 
diagnosed with ICP and GDM. The demographics and ma-
ternal results of the groups are presented in Table 2.
When compared, there was no significant difference in 
maternal age between the groups (p = 0.38). Patients were 
analyzed by gravidity and parity. The results revealed higher 
incidence of multigravidity and multiparity in non-GDM 
group than in GDM group but the difference was not sta-
tistically significant (p > 0.05). Maternal results showed that 
pre-pregnancy BMI ≥ 25 kg/m2 was significantly more often 
seen in patients in GDM group (p = 0.039). On the other 
hand, weight gain was observed as not significantly higher 
in non-GDM group than GDM group (12.19 kg vs 10.82 kg). 
The diagnosis of GDM was performed between 24–28 
gestational age. The 75 g OGTT results revealed signifi-
cant difference between non-GDM group and GDM group. 
Furthermore, the groups differed in fasting glucose level 
results (p = 0.002). 
Most of our patients had preterm delivery. We divided 
them into 3 groups: delivery below 34 Hbd, delivery be-
tween 34–36 Hbd and delivery above 36 Hbd. Most of pa-
tients from both groups had delivery between 34–36 Hbd. 
When compared, non-GDM and GDM group did not differ 
significantly in amount of given births in each from above 
described 3 groups (p = 0.33). 
The study group was also analyzed based on the route of 
delivery. In the non-GDM group rate of cesarean section was 
71.2% and in the GDM group 76.9%. The route of delivery did 
not differ significantly between the two groups (p = 0.396). 
Based on our results gestational diabetes mellitus had 
no significant impact on the route of delivery in patients 
diagnosed with ICP.
Laboratory liver function tests results of the study 
group are presented in the Table 3. The study re-
vealed that bile acids were not statistically higher in 
non-GDM group than in GDM group (34.27 vs 25.86; 
Table 2. Maternal results and delivery data analysis
Variable Non-GDM group (74 patients)
GDM group 
(28 patients) p value
Age [years] 31.51 ± 4.5 32.42 ± 4.56 0.38
Multigravida [%] 60% 46.15% 0.22
Multiparous [%] 50% 39.29% 0.34
Pre-pregnancy BMI ≥ 25kg/m² [%] 24,32% 50% 0.039
Gestational weight gain [kg] 12.19 ± 4.91 10.82 ± 6.34 0.26
FGL 81.91 ± 8.04 90.84 ± 18.53 0.002
0h OGTT 79.72 ± 6.72 91.96 ± 19.6 0.005
1h OGTT 118.57 ± 25.37 175.28 ± 45.77 0.00002
2h OGTT 103.55 ± 22.98 154.28 ± 37.97 0.00001
Gestational age 252.6 ± 15.6 251.0 ± 17.2 0.74
Delivery < 34 Hbd 8.1% 0% 0.33
Delivery 34–36 Hbd 68.9% 78.6% 0.33
Delivery > 36 Hbd 23% 21.4% 0.33
Vaginal delivery 28.8% 23.1% 0.396
Cesarean section 71.2% 76.9% 0.396
Birth weight [g] 2899.9 ± 617.2 2885.8 ± 736.93 0.08
Table 3. Laboratory liver function tests
Variable Non-GDM group (74 patients)
GDM group 
(28 patients) p value
Total bilirubin level 1.04 ± 2.13 0.78 ± 1.36 0.013
ALT [range] 6–1031 13–475 0.27
AST [range] 14–469 29–201 0.12
Bile acids < 40umol/L 71.2% 79.2% 0.73 
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p = 0.33). Similarly, the transaminases mean results 
(ALT and AST) showed no significant difference be-
tween non-GDM and GDM group (ALT: 194.35 vs 147.77, 
p = 0.27; AST: 110.2 vs 78.07, p = 0.12). Figure 3 and 4 
represent the results of ALT and AST describing mean and 
SEM in both groups. When the aminotransferases results 
were compared, it was observed wide range between the 
lowest and the highest rate of both ALT and AST in both 
groups included to the study.
As shown on Figure 5 most of patients included to the 
study (73%) developed mild cholestasis with bile acids below 
40 umol/L. When the severity of cholestasis was compared, 
the rate of mild cholestasis was 71.2% in non-GDM group 
an 79.2% in GDM group (p > 0.05). It was analyzed whether 
the levels of the serum bile acids have an impact on the 
prevalence and severity of GDM. The Figure 6 reveals the 
higher prevalence of GDM correlated with lower levels 
of serum bile acids. GDM grade 2 developed in patients 
only in the group with bile acids below 40 umol/L (4.55% 
of patients diagnosed with mild ICP developed GDMG2). 
On the other hand, analysis showed that the difference 
was not statistically significant (p = 0.73). When compared 
mean total bilirubin level was significantly higher in non-
GDM group compared to GDM group. 
The neonate’s results showed no significant difference 
in birth weight between the groups (p = 0.08). The preva-
lence of SGA was observed in 13.48% and LGA in 34.83% 
of neonates analyzed in the study. When compared it was 
statistically higher prevalence of small for gestational age 
in GDM group (p < 0.00001). Large for gestational age was 
statistically higher in non-GDM group than GDM group, 
36.92% and 29.17% respectively (p < 0.00001).
DISCUSSION
Nowadays Pathology of Pregnancy is an increasing 
problem worldwide. It is connected to sedentary lifestyle 
that has an impact on higher rate of obesity, diabetes and 
hypertension. 
There are many studies that confirm that weight before 
pregnancy has an impact on both fetus and pregnant 
woman. [8–11]. In our study, almost one quarter of patients 
with ICP and half of patients with ICP and GDM had BMI 
before pregnancy ≥ 25kg/m2. The difference between the 
groups was statistically different. Thus, it might be taken 
to account weight loss before pregnancy prevents com-
plications of pregnancy in some patients from the risk 
group [12, 13]. 
Most of our patients had preterm delivery. Our study 
revealed that most of our patients gave birth between 34 and 
36 week of gestation. According to the literature, it seems 
Figure 3. Alanine aminotransferase results, mean ± SEM
Figure 4. Asparagine aminotransferase results, mean ± SEM
Figure 5. Prevalence of mild and severe intrahepatic cholestasis in 
pregnancy
Figure 6. Prevalence of GDM in mild and severe cholestasis
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that GDM increases risk of preterm delivery [14]. Interestingly, 
in our study there was no statistical difference in number 
of preterm deliveries between GDM and non-GDM group. 
It might be correlated with the effective treatment of GDM 
in the hospital as other studies suggest [15].
Preterm delivery increases rate of cesarean sections. 
As other studies show GDM increases risk of CC instead of 
vaginal delivery in comparison to general population of 
pregnant women [16–18]. In our study the incidence of CC 
was over 70% percent in both studied groups. Interestingly, 
we found that having more than one pathology of pregnancy 
did not have significant impact on the route of delivery. 
Another problem that shows our study is age of women 
deciding for pregnancy. As our results revealed mean age 
of our study group was above 30 years old. It has an impact 
on both fetus and pregnant patients leading to increased 
risk of pathology of pregnancy. It has been proven that age 
above 35 years old is a risk factor of gestational diabetes [19]. 
Changing habits of population may lead in the nearest 
future to increased rate of this condition. Based on our 
results and other studies it may also have an impact on rate 
of intrahepatic cholestasis of pregnancy [6, 20].
Few studies revealed that bile acids metabolism corre-
lates with insulin resistance. It is thought, that bile acids are 
involved in the regulation of hepatic glucose metabolism by 
FXR-mediated pathways [21, 22]. Based on that some stud-
ies searched whether ICP might increase risk of GDM [20]. 
Martineau et al. evaluated the incidence of GDM in ICP pa-
tients is higher than in general population and the rate by 
then is 13.6% [23]. Our study confirmed the thesis. We re-
ceived higher proportion of the patients in our study (29.94%). 
It might relate to smaller study group included in our research 
work than in the mentioned article (57 724 vs 5676 patients). 
Furthermore 1st Department of Obstetrics and Gynecology, 
Medical University of Warsaw is Grade III referral Hospital 
and consequently it admits a higher rate of patients with 
pathology of pregnancy than is seen in general population. 
In our results ALT are higher than AST values in patients 
with ICP. ALT is thought to be more sensitive marker of ICP [1]. 
In one of the studies it was analyzed that the increase of ALT 
is 2–10-fold in serum levels than the rise of ALT [24]. 
The biggest advantage of this research was the uniform 
inclusion criteria of patients to the study. The other 
advantage is small amount of missing data. There are also 
few limitations of the study. First, it was conducted in Clinic 
with Pathology Ward, that might have an impact on rate and 
severity of both GDM and ICP. The glycaemia and bile acids 
level might be slightly higher than in general in patients with 
upon mentioned diagnoses as it is III Range of Reference 
Hospital admitting also the most severe cases. Secondly, 
as it was conducted in Warsaw it does not impress general 
population in Poland. It should be compared with the 
studies from smaller cities to have the point of view how 
both conditions correlate in general in Poland. Lastly, 
the study group was a small population and that might 
had an impact on not statistically different results in the 
study between the groups and based on that to not make 
definitive conclusions.
CONCLUSIONS
We found that ICP correlates with impaired glucose tol-
erance. These findings might have an impact on healthcare 
of the fetus and pregnant women with diagnosis of one of 
the mentioned conditions.  The results of the earlier studies 
are the evidence supporting the thesis about association 
between ICP and GDM. It might be taken into an account 
a consideration of screening for glucose intolerance in pa-
tients with diagnosis of new-onset cholestasis. To make 
clarify the steps regarding mentioned test more studies 
are required. It will help to find out the direct reason re-
sponsible for higher rate of coincidence of the upon two 
conditions. Consequently, it may have role in better care of 
the pregnant woman and fetal well-being. 
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